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Abstract
Background: Dysgerminoma is the most common malignant germ cell tumor of the ovary. This
malignancy can be associated with pure gonadal dysgenesis or Swyer syndrome, mixed gonadal
dysgenesis and partial gonadal dysgenesis.
Case presentation: Dysgerminoma developed in 3 phenotypic female patients with 46 XY pure
gonadal dysgenesis. All patients presented first with abdominopelvic mass. Laparatomy was done.
46 XY karyotype was made by lymphocyte culture. Then these patients underwent gonadectomy
that histopathology results were streak ovaries without evidence for malignancy. Two patients
received postoperative adjuvant therapy.
Conclusion: In Patients with Swyer syndrome the risk of dysgerminoma is high and gonadectomy
is recommended. Also 5% of dysgerminomas are discovered in phenotypic female and 46 XY
karyotype, thus in adolescent with dysgerminoimas and amenorrhea, karyotype should be done.
Background
Since 1955, when Swyer [1,2] first described two pheno-
typic women with gonadal dysgenesis without the stigma
of Turner syndrome (46, XY pure gonadal dysgenesis of
Swyer syndrome), several authors have reported over 74
tumoral growths of their dysgenetic gonads [3-19].
The propensity of tumor development in Swyer syndrome
is significant, a incidence of 20–30% is reported. The most
common tumor is the often-bilateral gonadoblastoma,
but dysgerminoma and even embryonal carcinoma also
seen [2]. Approximately 5% of dysgerminomas are discov-
ered in phenotypic females with abnormal gonads and 46
XY karyotype [1].
We present three patients with pelvic mass, of which two
patients, in spite of primary amenorrhea had nearly com-
plete secondary sex characteristic. Another patient had
secondary amenorrhea. All the patients had dysgermi-
noma, that underwent unilateral salpingoopherectomy
and two of these, received adjuvant therapy. Gonadec-
tomy after diagnosis of XY karyotype was done.
Case presentation
Case 1
A 20 years old girl (160 cm height and 57 kg weight) pre-
sented in September 1999 with 6 months history of lower
abdominal pain and gradual distention of abdomen.
Clinically, she was noted to have an abdominal mass
extending 4 cm above umbilicus. She had undergone an
ultrasonography, which showed a huge complex abdomi-
nopelvic mass arising from the right ovary. Additional
evaluation was negative for serum βHCG and AFP, but
CA125 was 110 IU/ml. The FSH was 34 mIU/ml, the LH
was 28 mIU/ml and serum estradiol was 36 pg/ml. Her
past medical history was negative except for primary
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amenorrhea. She had gradual breast development since
eleven years old and at her 1st visit, she had nearly com-
plete development of secondary sex characteristics. On
examination the abdomen was soft, non tender with a
palpable nontender fixed abdominopelvic mass. There
was no evidence of ascitis. In vaginal exam, there was a
normal length vagina and cervix. Uterus was palpable in
rectovaginal exam.
Exploratory laparotomy revealed a normal (infantile)
uterus and tubes and a huge abdominopelvic mass 25 cm
diameter and 3100 g weight, which was resected (figure
1). Gonads on the contralateral side were normal.
Mass resection was performed and uterus was preserved.
The cut surface of the tumor was soft; light gray with focal
areas of hemorrhage. Pathology revealed ovarian dysger-
minoma of the right ovary characterized by neoplastic
cells that had round to ovoid or slightly irregular nuclei
with coarse clumped chromatin and prominent nucleoli.
Mitoses were numerous. The cytoplasm was clear to
lightly eosenophyilic and cell borders were well defined.
Aggregation of tumor cells was separated by fibrous septa
that contained scattered lymphocytes (figure 2). The
tumor was classified as stage IIIC.
Full metastatic work-up was negative. Karyotype was con-
sistent with 46 XY (nonmosaic). At the end of the second
course of chemotherapy (Bleomycin plus etoposide plus
cisplatin), liver enzyme rose significantly and jaundiced,
and then due to probable drugs induced cholestatic hepa-
titis, she was referred to radiotherapy. She received 4000
cGy and become severely leucopenic. One-month later
exploration laparoscopy was performed and one residual
gonad or streak gonad was found at the opposite site and
she underwent gonadectomy. Histopathological examina-
tion showed a streak ovary without evidence for malig-
nancy. She received estrogen and progesterone
postoperatively, until now and she has monthly men-
strual flow.
Case 2
A  19 years old female G0P0 (159 cm high and 55 kg
Wight) with primary amenorrhea was referred to the
Tehran University Gynecology cancer center with 7
months history of abdominal pain, which progressed to
abdominal distension. Evaluation included pelvic exam
and ultrasound, which documented a solid complex mass
of 123 × 80 mm size. The first sonographic diagnosis was
hematometrocolpos or endometriosis. Computerized
tomography scan confirmed no upper abdominal disease
or lymphadenopathy and confirmed pelvic mass and no
ascitis. Additional evaluation was normal for serum
CA125 and AFP and βHCG. FSH was 80 mIU/ml, LH was
38 mIU/ml, estradiol was 29 pg/ml and LDH was 1450
IU/ml. Her past medical history was negative. Her karyo-
type was reported as 46 XY, thus she underwent laparot-
omy, peritoneal washing, resection of tumor (in right
gonad), Para aortic and bilateral lymphadenectomy and
staging biopsies were done. Infantile uterus preserved and
left gonad was resected. The right ovary measured 120
mm and weight 1700 g. Pathology revealed dysgermi-
noma in right ovary and Tumor was classified as stage IIB.
Histological examination of left ovary was infantile gonad
including fibrous bands that don't seen malignancy.
Adjuvant chemotherapy consisted of 6 cycle of BEP after
surgery was administered. Chest X-ray, abdominal and
pelvic ultrasound and biochemical markers after 4 years
remain normal. She receives estrogen and progesterone
and has menstrual flow.
Case 3
A 17 years old girl (168 cm high and 59 kg weight) with
secondary amenorrhea was referred to our center in Octo-
ber 2004 with 4 months history of abdominal pain and
distention of abdomen. Evaluation prior to referral
included an ultrasound, which documented a complex
abdominopelvic mass measured 95 × 80 mm thought to
arise from the right ovary. Tumor markers were evaluated,
that serum BHCG and AFP was normal, but CA125 was 90
IU/ml, LDH 844 IU/ml FSH 45 mIU/ml, LH 27 mIU/ml
and estradiol 44 pg/ml. Past medical history in this
patient was negative, except for secondary amenorrhea.
She had breast development (tanner4) since 13 years old
and at her 1st visit she had nearly complete development
of secondary sex characteristic. In rectal exam, there was a
normal length vagina and cervix, and uterus was palpable.
Laparatomy revealed a normal uterus and tubes and a
large pelvic mass, which resected. In left side there was no
gonadal lesion. Mass resection was performed. Uterus was
Dysgerminoma Figure 1
Dysgerminoma. An usually large tumor, showing a smooth 
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preserved. Pathology revealed ovarian dysgerminoma of
the right ovary. Full metastatic work-up was negative.
Karyotype was consistent with 46 XY (pure). Due to tumor
was classified as stage IA grade 1, adjuvant therapy was not
commented. The patient admitted for unilateral gonadec-
tomy. Histopathological examination of left ovary
showed a streak ovary that displays ovarian stroma but no
follicles. She had been followed for 18 months and with
estrogen plus progesterone had menses out flow.
Discussion
Gonadal dysgenesis is characterized by the histology of
the gonads of affected patient and based on that the 46 XY
gonadal dysgenesis may be divided in to 3 histological
categories:
1) Complete or pure gonadal dysgenesis or Swyer syn-
drome. The patients are phenotypic females with a 46 XY
karyotype and hypoplastic gonads without germ cells.
They present most often with primary amenorrhea with
normal stature. The gonads are usually streaks, but there
may be some development of secondary sexual character-
istics as well as a few episodes of uterine bleeding [1,2].
2) Mixed gonadal dysgenesis that primary amenorrhea is
associated with various mosaic status, the most common
of which is 45X/46xx. When compared to the pure 45X
cell line, individuals with 45X/46XX are taller and have
fewer abnormalities. Spontaneous menstruation occurs in
approximately 20% of these patients.
3) Partial gonadal dysgenesis. They have karyotype 46XX
with part of one of the X chromosomes missing. The phe-
notype is variable depending on the amount and location
of the missing genetic material. In 46 XY partial gonadal
dysgenesis individuals there is some testicular develop-
ment; therefore they present as newborns with ambiguous
genitalia.
The etiology of 46 XY gonadal dysgenesis is though to be
a short arm Y chromosome deletion involving SRY, a
mutation in other genes that leads to inhibition of SRY
function or mutation of SRY function [2].
To date, 20% of 46 XY pure gonad dysgenesia are
explained by a mutation or a deletion in SRY. In 80%, SRY
is apparently normal. A female patient with an XY Karyo-
type who has a Palpable mullerian system, normal female
testosterone levels, and lack of sexual development has
Swyer syndrome, Tumor transformation in the gonadal
ridge can occur at any age [1-3].
The incidence of neoplasia in patients with gonadal dys-
genesis is wider than reported. In 50 reported cases, there
were 11 malignancy, 15 adenoma and 10 benign cases; a
22% incidence of malignancy and a 52% incidence of
neoplasia. More recent series indicate a lower overall inci-
dence of gonadal tumors about 5–10% but in Swyer syn-
drome the risk of gonadal neoplasia is high (20–30%),
dictating early prophylactic removal of these dysgenetic
gonads (2). Also Slowikowska [7] reported, neoplasia
may be occurred in 16.7% to 23.1% of patients with
gonadal dysgenesis.
Uehara et al., and Amice showed that SRY may play a for-
mation of gonadal tumors, especially dysgerminoma in
Swyer syndrome [20,21]. However intra abdominal
gonads should be removed as early in life as possible
because of the known risk of tumor development [2].
The patients with 46 XY gonadal dysgenesis patients are
diagnosed in early adolescence with delayed pubertal
development. As expected they show elevated gonadotro-
pins, normal female levels of androgens and low levels of
estrogens, female external genitalia, uterus and fallopian
tubes. Minimal breast enlargement reflects peripheral aro-
matization of androgens. Menstrual function suggests
tumor development in the streak gonad. These streaks
often display ovarian stroma but no follicles.
Dysgerminoma Figure 2
Dysgerminoma. The clamps of tumor cells are separated by 
fibrous stromal strands, which are infiltrated by inflammatory 
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In our cases, gonadotropins were about postmenopausal
level (FSH>20 IU/L) and estradiol was at the low end of
normal (40–400 pg/ml) in reproductive ages. Also men-
strual function and breast enlargement associated with
gonadotropin – independent precocious puberty. In this
patient, estrogen or androgens produced by ovarian
tumor [22].
In accordance with Scully view the germ cells of the dys-
germinoma seem the most likely source of the HCG,
whereas the increased androgens were probably produced
by the cells of the gonadoblastoma. Both hormone levels
fell markedly on complete removal of the gonadal masses
[19]. But in our cases BHCG levels were normal and testo-
sterone was not measured before surgery.
Estrogen and progestin sequential therapy supports
female secondary sex development in patients with
gonadal dysgenesis and they are potential candidate for
donor oocyte [1,2].
Kawai et al., analyzed seven tumor markers in germ cell
tumors of the ovary. He showed positive rate of CA125
was over 50% in all tumor types except mature cystic ter-
atoma. So CA125 was useful for the screening of malig-
nant germ cell tumors. Dysgerminoma had a high positive
rate of LDH. Positive rate of AFP was 11.8% in dysgermi-
noma, 100% in yolk sac tumor and 61.9% in immature
teratoma [23].
In this article the plasma levels of CA125 in cases 1 and 3
were higher than expectant range, but in case2 were nor-
mal. LDH in case 2 and 3 were high and AFP in all patients
was normal.
Dysgerminoma is the most common malignant germ cell
tumor of the ovary. It can be found either in a pure form
or mixed with other germinal elements. Therefore in pre-
menarchal patients with a pelvic mass, the karyotype
should be determined. About 65% of dysgerminomas are
stage I at diagnosis. About 85–90% of stage I tumors are
confined to one ovary; 10–15% is bilateral. Dysgermi-
noma is the only germ cell malignancy that has this signif-
icant rate of bilaterality, other germ cell tumors being
rarely bilateral [1].
The treatment of patient with early disgerminoma is pri-
marily surgical, including resection of the primary lesion
and proper surgical staging. Chemotherapy and/or radia-
tion are administered to patients with metastatic disease.
In patients whose contra lateral ovary has been preserved,
disease can develop in 5% to 10% of the retained gonads
over the next 2 years [1].
These three cases presented demonstrate the occurrence of
dysgerminoma in patients with Swyer syndrome. There is
a relative paucity of published case studies on dysgermi-
noma in female patients with pure dysgenetic gonad. The
development of secondary sex characteristics in these
three patients is most unusual. The sexual development
were complete and only along females lines, furthermore
these patients had withdrawal bleeding response to estro-
gen and progesterone. A small number of cases have
reported that unusual female secondary sexual develop-
ment in patients with 46 XY gonadal digenesis [24].
Conclusion
Bilateral dysgenesis of the testes (Swyer syndrome)
affected individuals has an XY karyotype but normal
(infantile) female external and internal genitalia. In these
patients the risk of dysgerminoma is high and gonadec-
tomy was recommended. Also in 5% of cases of dysgermi-
noma, XY karyotype is seen. Thus in adolescents patients
with dysgerminoma with primary amenorrhea and sec-
ondary amenorrhea, Karyotype should be done. Also
menstrual function in patients with 46 XY karyotype may
be associated with estrogen secretion of tumoral lesion
and investigation of gonads is recommended.
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